The Immune Tolerance Network (ITN) has announced a new clinical research fellowship program that will provide promising junior-level faculty with intensive, hands-on training in the planning, design and implementation of clinical trials. The "ITN Scholars Program" aims to begin addressing the need for well-trained clinical research professionals in the area of immune tolerance. The one-year fellowships will provide salary support for one or two scholars annually with additional allowances for travel and housing.
The ITN Scholars Program was designed to help create a pool of highly trained academic researchers with broad clinical trials experience in the emerging field of immune tolerance therapies.
Mohamed H. Sayegh, M.D., Professor of Medicine at Harvard Medical School and Chair of the ITN Scholars search committee, says that effectively planning clinical trials of emerging immune-based therapies requires a rare combination of skills that are difficult to acquire in one academic institution.
"One needs to have a thorough understanding of both the medical aspects of immunological conditions, and the scientific and biological bases of the immune system. On top of that, one needs intimate knowledge of the logistics of planning and implementing clinical trials something best learned by hands on experience," says Sayegh.
Successful applicants will therefore have the opportunity to develop an intimate knowledge of the scientific, medical and regulatory aspects of clinical trial design and implementation through close mentorship with ITN Clinical Directors. Working primarily from the San Francisco offices of the ITN Clinical Trials Group under the supervision of ITN Clinical Directors, the fellow will also interact closely with regulatory personnel at the National Institutes of Health and with biostatistical and laboratory personnel at the ITN's Tolerance Assay Group in Bethesda Maryland.
Upon completion of the progPage: 1 2 Related medicine news :1
Contact: Jeffrey B. Matthews
Immune Tolerance Network
. Scholarship to attract top students for optometry2
. Mayo Medical School students selected for Howard Hughes Medical Institute Research Scholars Program3
. Study provides new estimates of the causes of child mortality worldwide4
. Newly identified gene cluster on mouse X chromosome provides insights into fertility5
. Pegaptanib provides benefit for neovascular age-related macular degeneration6
. Study provides clues to alcohols cancer connection7
. International study provides culture-by-culture clues to family violence and abuse8
. Skin sterol provides new information about heart disease risk9
. Novel drug-antidote strategy provides greater control of drug action10
. Survey provides comprehensive look at use of complementary and alternative medicine in US11
. Patient safety study provides first national estimate of adverse events in Canadian hospitals